Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case

Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case

Fang Liu, Fei Qi, Xiuying Zhang, Mei Cao, Shiguang Peng Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Fang Liu, Email roseliufang@qq.comAbstract: Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-...

Full description

Bibliographic Details
Main Authors:	Liu F, Qi F, Zhang X, Cao M, Peng S
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-07-01
Series:	Clinical, Cosmetic and Investigational Dermatology
Subjects:	primary cutnaeous diffuse large b-cell lymphoma leg type，rituximab plus cyclophosphamide doxorubicin vincristine and prednisone (r-chop) ，remission
Online Access:	https://www.dovepress.com/germinal-centre-related-primary-cutaneous-diffuse-large-b-cell-lymphom-peer-reviewed-fulltext-article-CCID

Similar Items

Serum Albumin Levels Strongly Predict Survival Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Combined Chemotherapy
by: Hiroto Kaneko, et al.
Published: (2022-01-01)

Life-threatening Pneumocystis jiroveci Pneumonia with Cytomegalovirus Coinfection in a Follicular Lymphoma Patient During Rituximab-based Chemotherapy
by: Mu-Chun Yang, et al.
Published: (2024-01-01)

Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study
by: Fatemeh Riasi, et al.
Published: (2023-12-01)

Primary Bone Marrow Diffuse Large B-Cell Lymphoma in a frail and older patient: long lasting remission by R-CHOP
by: Pasquale Niscola
Published: (2014-08-01)

Hemodynamic and Biochemical Alterations in Dogs with Lymphoma after Induction of Chemotherapy
by: D.M. Fine, et al.
Published: (2014-05-01)

Use of Plasmapheresis and Immunosuppressants to Treat Diffuse Alveolar Hemorrhage in a Patient with Granulomatosis with Polyangiitis
by: Yasar Sattar, et al.
Published: (2019-07-01)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
by: Steven Habbous, et al.
Published: (2020-10-01)

Transient Wheal Attack Corresponding to the Tumor Lesions of Primary Cutaneous Diffuse Large B Cell Lymphoma, Leg Type after Successive Rituximab Treatment
by: Saori Itoi, et al.
Published: (2014-09-01)

Oral cyclophosphamide treatment for clinical periocular inflammation of unknown origin
by: Arash Maleki, et al.
Published: (2024-10-01)

Recurrent autoimmune hemolytic anemia in splenic marginal zone lymphoma
by: Oreoluwa Oladiran, et al.
Published: (2018-07-01)

A case of diffuse large B-cell lymphoma with interstitial pneumonia
by: Ge Song, et al.
Published: (2023-07-01)

Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphoma
by: Jake G. Besch‐Stokes, et al.
Published: (2023-12-01)

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
by: Gloria Margiotta-Casaluci, et al.
Published: (2023-03-01)

Leuconostoc sp. Meningitis in a Patient Treated with Rituximab for Mantle Cell Lymphoma
by: Hrvoje Holik, et al.
Published: (2015-07-01)

Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I studyResearch in context
by: Suying Lu, et al.
Published: (2024-07-01)

Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide
by: Kamel El-Reshaid, et al.
Published: (2013-04-01)

A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy
by: Yi Wang, et al.
Published: (2024-12-01)

A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India
by: Sabha Mushtaq, et al.
Published: (2024-11-01)

Successful management of Kaposiform Hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature
by: Matteo Chinello, et al.
Published: (2018-07-01)

A 15-Year-Old Boy with Primary Maxillary Bone Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Relapsed with Rib Metastasis after Spontaneous Remission of a Maxillary Bone Lesion: A Case Report and Literature Review
by: Kaito Aizawa, et al.
Published: (2023-05-01)

CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule
by: Amy Xiao, et al.
Published: (2023-09-01)

Symptomatic Follicular Lymphoma: Complete Remission After Chemoimmunotherapy with Bendamustine–Rituximab
by: Wulyo Rajabto, et al.
Published: (2024-04-01)

Early complete response of primary bone marrow B‐cell lymphoma treated with rituximab‐based CHOP therapy, assessed by flow cytometry and immunogloblin heavy chain rearrangement
by: Yoshimi Nabe, et al.
Published: (2021-08-01)

Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy
by: Brian Lee, et al.
Published: (2023-08-01)

Ongoing trials in low-grade lymphoma
by: Alexander Burchardt
Published: (2011-10-01)

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study
by: Renée Ysermans, et al.
Published: (2023-01-01)

A rare case of CD20− primary cutaneous diffuse large B-cell lymphoma, leg type
by: Juliette M. Kersten, MD, et al.
Published: (2024-12-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications
by: Haotian Shi, et al.
Published: (2023-05-01)

Primary cutaneous diffuse large B-cell lymphoma, leg type, presenting as subcutaneous nodules: Case series and comparison of treatment outcomes
by: Jake G. Besch, MD, et al.
Published: (2023-11-01)

A case of cutaneous large B-cell lymphoma of the legs appearing as chronic venous ulceration
by: Alfredo Rossi, et al.
Published: (2012-05-01)

Diffuse large cell lymphoma of the lacrimal sac may mimic as acute dacryocystitis
by: Soma Rani Roy, et al.
Published: (2023-01-01)

Results of CHOP chemotherapy for diffuse large B-cell lymphoma
by: A.E. Hallack Neto, et al.
Published: (2006-10-01)

Primary breast lymphoma: A single-institute experience in Taiwan
by: Che-Wei Ou, et al.
Published: (2014-10-01)

R-CHOP-Associated Graves’ Hyperthyroidism
by: Natalie Mora, et al.
Published: (2019-07-01)

Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
by: Cheng Xue, et al.
Published: (2023-09-01)

Pulmonary involvement in Anti‐Neutrophil Cytoplasmic Antibody Associated Vasculitis: A single centre case series
by: Peter T. Bell, et al.
Published: (2022-11-01)

Intravascular Large B-cell lymphoma: A case series and review of literatures
by: Yuen-Chin Ong, et al.
Published: (2021-08-01)

Spontaneous Remission and Concomitant Progression in a Patient with DLBCL
by: Eun Ji Han, et al.
Published: (2020-11-01)